Skip to main content
All lobbying filings

INDIVIOR INC

Lobbying for INDIVIOR INC

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate · $250,000.00 expenses · posted Apr 20, 2026

Official filing document

 Lobbying activity 1
Health Issues

Issues related to regaining status for long acting injectables on the BOP formulary, and changes to CMS bundled payments.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem